82 related articles for article (PubMed ID: 26806825)
1. A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
Rocco MV; Cheung AK
Kidney Int; 2016 Feb; 89(2):261-3. PubMed ID: 26806825
[TBL] [Abstract][Full Text] [Related]
2. [The results of SPRINT study from the point of nephrology].
Monhart V
Vnitr Lek; 2016; 62 Suppl 6():55-57. PubMed ID: 28124932
[TBL] [Abstract][Full Text] [Related]
3. [Managing hypertension in patients with chronic kidney disease - implications of the SPRINT study].
Wojtaszek E; Głogowski T
Wiad Lek; 2016; 69(5):742-744. PubMed ID: 28033599
[TBL] [Abstract][Full Text] [Related]
4. Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
Phillips RA; Xu J; Peterson LE; Arnold RM; Diamond JA; Schussheim AE
J Am Coll Cardiol; 2018 Apr; 71(15):1601-1610. PubMed ID: 29525494
[TBL] [Abstract][Full Text] [Related]
5. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
García-Donaire JA; Segura J; Cerezo C; Ruilope LM
Blood Press; 2011 Dec; 20(6):322-34. PubMed ID: 21936729
[TBL] [Abstract][Full Text] [Related]
6. Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.
Chertow GM; Beddhu S; Lewis JB; Toto RD; Cheung AK
J Am Soc Nephrol; 2016 Jan; 27(1):40-3. PubMed ID: 26553785
[TBL] [Abstract][Full Text] [Related]
7. [Blood pressure: the lower the better? Maybe yes].
Verdecchia P; Angeli F; Aita A; Bartolini C; Garofoli M; Reboldi G
G Ital Cardiol (Rome); 2016 May; 17(5):335-8. PubMed ID: 27310905
[TBL] [Abstract][Full Text] [Related]
8. [More rigorous blood pressure control yields results in high risk patients. American SPRINT provides increased evidence of the benefits of prevention].
Gottsäter A; Kahan T; Nilsson P
Lakartidningen; 2015 Dec; 112():. PubMed ID: 26695402
[No Abstract] [Full Text] [Related]
9. Prehypertension: is it relevant for nephrologists?
Kaplan NM
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1381-3. PubMed ID: 19608711
[TBL] [Abstract][Full Text] [Related]
10. Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control.
Ewen S; Lobo MD; Pathak A; Schmieder RE; Tsioufis C; Wijns W; Mahfoud F
EuroIntervention; 2016 Aug; 12(6):809-12. PubMed ID: 27542797
[No Abstract] [Full Text] [Related]
11. A SPRINT to the Finish.
Drazen JM; Morrissey S; Campion EW; Jarcho JA
N Engl J Med; 2015 Nov; 373(22):2174-5. PubMed ID: 26551058
[No Abstract] [Full Text] [Related]
12. Treatment of hypertension in Italian nephrology out-patient clinics: the THIN Study.
Russo D; Andreucci M; De Blasio A; Frattolillo P; Andreucci VE
Semin Nephrol; 2005 Nov; 25(6):431-4. PubMed ID: 16298268
[TBL] [Abstract][Full Text] [Related]
13. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study.
De Nicola L; Minutolo R; Zamboli P; Cestaro R; Marzano L; Giannattasio P; Cristofano C; Chimienti S; Savica V; Bellinghieri G; Rapisarda F; Fatuzzo P; Conte G;
Semin Nephrol; 2005 Nov; 25(6):425-30. PubMed ID: 16298267
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
[TBL] [Abstract][Full Text] [Related]
15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
16. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
17. Systolic blood pressure and mortality.
Kondo M
Lancet; 2000 Aug; 356(9230):682-3. PubMed ID: 10968466
[No Abstract] [Full Text] [Related]
18. Hypertension and stroke: an appraisal of the evidence and implications for clinical management.
Lackland DT; Voeks JH; Boan AD
Expert Rev Cardiovasc Ther; 2016; 14(5):609-16. PubMed ID: 26782835
[TBL] [Abstract][Full Text] [Related]
19. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
[TBL] [Abstract][Full Text] [Related]
20. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].
Schühlen H; Abts M; Kastrati D
Herz; 2007 Aug; 32(5):419-25. PubMed ID: 17687532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
